Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-19

Clinical Trial Update: Efficacy and Safety of Different Doses of Indacaterol [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of different doses of indacaterol in asthma. The results were posted in August 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indacaterol (indacaterol)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2011-08-19